See also this year's filing and all EDGAR filings for this company.
PDF Report 0001061027_2017_Viracta_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001061027, Viracta Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,231,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 10,939,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,115,000 |
| 9 | ResearchAndDevelopmentExpense | 22,881,000 |
| 10 | remainder_Expenses | 1,721,000 |
| 11 | remainder_Revenues | 2,536,000 |
| 12 | remainder_NetIncome | 158,000 |
| 13 | remainder_ComprehensiveNetIncome | -11,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,234,000 |
| 1 | Liabilities | 10,939,000 |
| 2 | Expenses | 40,717,000 |
| 3 | Revenues | 2,536,000 |
| 4 | StockholdersEquity | 32,295,000 |
| 5 | NetIncome | -38,023,000 |
| 6 | ComprehensiveNetIncome | -38,028,500 |
| 7 | BaseVar | 48,797,500 |
| 8 | EconomicCapitalRatio | 0.647 |
Edgar->Model Mapping
Feature Distribution
